Skip to content

A Telerehabilitation Program for SCI

Feasibility and Effectiveness of Home-based Telerehabilitation Program for Recovery of Upper Limb Functions in Incomplete Spinal Cord Injury

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04977037
Enrollment
20
Registered
2021-07-26
Start date
2021-07-01
Completion date
2024-04-02
Last updated
2025-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incomplete Spinal Cord Injury

Keywords

Cervical Spinal Cord Injury, upper limb, tDCS, telerehabilitation

Brief summary

This study evaluates a remotely supervised, home-based therapeutic program to improve upper-limb voluntary movement in adults with tetraplegia caused by incomplete spinal cord injury (iSCI).

Detailed description

Spinal Cord Injury (SCI) has been associated with serious reduction in functional independence. Despite compelling evidence that treatment intensity has a profound effect on motor recovery only a small fraction of SCI population are able to receive intensive in-clinic treatment. Difficulty traveling to the clinic, poor adherence to assignments and high cost are limiting factors. Currently, telerehabilitation programs are emerging as an alternative effective method of delivery for rehabilitation services. The literature and our preliminary findings support the model that augmentation of activity in spared corticospinal tract (CST) axons is a critical mechanism of motor improvement, and furthermore that CST activity can be increased by repetitive motor training and by electrical stimulation of the primary motor cortex (M1). However, there is still lack of knowledge on safety, feasibility and efficacy of remotely- supervised home-based therapy programs that incorporates non-invasive brain stimulation and high intensity repetitive arm exercises. To address these questions, 36 adults (above 18 years) with cervical SCI will be randomly assigned to two groups in a 2:1 ratio (active stimulation group, n=24 vs control group, n=12) and receive daily treatment, 10 sessions, over 2-weeks. The anodal tDCS will be applied over primary motor cortex (M1) at an intensity of 2mA for 20 minutes and proceed with 60 minutes of repetitive arm and hand training. Primary outcome measure is change in Graded and Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) from baseline to immediately after treatment and 4-weeks follow-up. The session will be supervised in real-time via videoconferencing.

Interventions

DEVICEActive tDCS

Anodal tDCS will be placed over the primary motor cortex and delivered at 2mA for 20 minutes. Immediately after stimulation ceases, participants will continue with unilateral repetitive arm and finger exercises for 60 minutes. Exercise difficulty will gradually be increased and adjusted per participant's tolerance.

DEVICESham tDCS

Anodal tDCS will be placed over the primary motor cortex and delivered at 2mA for 20 minutes. Immediately after stimulation ceases, participants will continue with unilateral repetitive arm and finger exercises for 60 minutes. Exercise difficulty will gradually be increased and adjusted per participant's tolerance.

Sponsors

Mission Connect a project of TIRR Foundation
CollaboratorUNKNOWN
The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

active or sham tDCS

Intervention model description

Double-blind, randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. diagnosis of a chronic incomplete cervical lesion as defined by the American Spinal Injury Association Impairment scale classification and at least for 6 months post-injury; 2. upper-extremity weakness associated with tetraplegia with minimal residual thumb and index; finger movement sufficient to grip small objects such as marble; 3. no brain injury; 4. no planned alteration in upper-extremity therapy or medication for muscle tone during the course of the study; 5. no contradiction to tDCS; 6. access to internet at home.

Exclusion criteria

1. prior history of seizure; 2. chronic use of neuroactive medication (e.g., neurostimulants, anticonvulsants, or antidepressants); 3. any joint contracture or severe spasticity in the affected upper extremity, as measured by a Modified Ashworth Score ≥ than 3 out of 4.

Design outcomes

Primary

MeasureTime frameDescription
Arm and Hand Function as Assessed by Score on the Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)BaselineThe Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP) assesses the integration of sensorimotor hand and upper limb impairment and function. GRASSP total score will be reported, and it ranges from 0 to 116, with a higher score indicating a higher level of arm and hand function.

Secondary

MeasureTime frameDescription
Adherence With the Therapy as Assessed by the Number of Participant Drop-outsBetween enrollment and 6 weeks
Feasibility of Home Intervention as Indicated by Participants' Perceptions of Usefulness of the Intervention as Assessed by the Visual Analog Scale (VAS)Day 10Participants rated the usefulness of the interventions on a scale of 0 to 10, with 0 indicating not useful at all and 10 indicating very useful.
Grip StrengthBaselineMaximum force generated by hand muscles and measured with a hand-held dynamometer
Adherence With the Therapy as Assessed by the Number of Sessions Participants AttendedTreatment Day 1- Day 10
Number of Participants Who Had Adverse Eventsfrom baseline to 6 weeks
Feasibility of Home Intervention as Indicated by Participants' Perceptions of Level of Difficulty of Using tDCS as Assessed by the Visual Analog Scale (VAS)Day 10Participants rated the level of difficulty of using tDCS on a scale of 0 to 10, with 0 indicating not difficult at all and 10 indicating very difficult
Feasibility of Home Intervention as Indicated by Participants' Perceptions of Level of Difficulty of Using Exercise Equipment as Assessed by the Visual Analog Scale (VAS)Day 10Participants rated the level of difficulty of using exercise equipment on a scale of 0 to 10, with 0 indicating not difficult at all and 10 indicating very difficult.
Self Care as Assessed by Score on the Self Care Subscale of the Spinal Cord Injury Independence Measure (SCIM III)BaselineTotal score on the Self Care Subscale of the Spinal Cord Injury Independence Measure (SCIM III) ranges between 0 to 20, with a higher score indicating a higher level of independence in daily functions.

Countries

United States

Participant flow

Participants by arm

ArmCount
Active tDCS
Anodal transcranial direct current stimulation (tDCS) targeting the primary motor cortex delivered at 2mA for 20 minutes Active tDCS: Anodal tDCS will be placed over the primary motor cortex and delivered at 2mA for 20 minutes. Immediately after stimulation ceases, participants will continue with unilateral repetitive arm and finger exercises for 60 minutes. Exercise difficulty will gradually be increased and adjusted per participant's tolerance.
13
Sham tDCS
Sham transcranial direct current stimulation (tDCS) targeting the primary motor cortex delivered at 2mA for 20 minutes Sham tDCS: Anodal tDCS will be placed over the primary motor cortex and delivered at 2mA for 20 minutes. Immediately after stimulation ceases, participants will continue with unilateral repetitive arm and finger exercises for 60 minutes. Exercise difficulty will gradually be increased and adjusted per participant's tolerance.
7
Total20

Baseline characteristics

CharacteristicActive tDCSSham tDCSTotal
Age, Continuous46.3 years
STANDARD_DEVIATION 16.5
45.8 years
STANDARD_DEVIATION 12.1
46.2 years
STANDARD_DEVIATION 14.8
Asia Impairment Scale Classification
A
0 Participants0 Participants0 Participants
Asia Impairment Scale Classification
B
5 Participants2 Participants7 Participants
Asia Impairment Scale Classification
C
1 Participants5 Participants6 Participants
Asia Impairment Scale Classification
D
7 Participants0 Participants7 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants1 Participants4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
10 Participants6 Participants16 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
2 Participants4 Participants6 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants0 Participants1 Participants
Race (NIH/OMB)
White
10 Participants3 Participants13 Participants
Region of Enrollment
United States
13 participants7 participants20 participants
Sex: Female, Male
Female
2 Participants1 Participants3 Participants
Sex: Female, Male
Male
11 Participants6 Participants17 Participants
Time Since Injury84 Months
STANDARD_DEVIATION 104.2
71 Months
STANDARD_DEVIATION 85.12
79.89 Months
STANDARD_DEVIATION 96.41

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 130 / 7
other
Total, other adverse events
1 / 132 / 7
serious
Total, serious adverse events
0 / 130 / 7

Outcome results

Primary

Arm and Hand Function as Assessed by Score on the Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)

The Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP) assesses the integration of sensorimotor hand and upper limb impairment and function. GRASSP total score will be reported, and it ranges from 0 to 116, with a higher score indicating a higher level of arm and hand function.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Active tDCSArm and Hand Function as Assessed by Score on the Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)64.9 score on a scaleStandard Deviation 25.5
Sham tDCSArm and Hand Function as Assessed by Score on the Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)58.3 score on a scaleStandard Deviation 31.1
Primary

Arm and Hand Function as Assessed by Score on the Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)

The Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP) assesses the integration of sensorimotor hand and upper limb impairment and function. GRASSP total score will be reported, and it ranges from 0 to 116, with a higher score indicating a higher level of arm and hand function.

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Active tDCSArm and Hand Function as Assessed by Score on the Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)68 score on a scaleStandard Deviation 28.8
Sham tDCSArm and Hand Function as Assessed by Score on the Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)59.7 score on a scaleStandard Deviation 32.6
Primary

Arm and Hand Function as Assessed by Score on the Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)

The Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP) assesses the integration of sensorimotor hand and upper limb impairment and function. GRASSP total score will be reported, and it ranges from 0 to 116, with a higher score indicating a higher level of arm and hand function.

Time frame: 6 weeks

ArmMeasureValue (MEAN)Dispersion
Active tDCSArm and Hand Function as Assessed by Score on the Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)72.1 score on a scaleStandard Deviation 28.3
Sham tDCSArm and Hand Function as Assessed by Score on the Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)57.7 score on a scaleStandard Deviation 37.7
Secondary

Adherence With the Therapy as Assessed by the Number of Participant Drop-outs

Time frame: Between enrollment and 6 weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Active tDCSAdherence With the Therapy as Assessed by the Number of Participant Drop-outs2 Participants
Sham tDCSAdherence With the Therapy as Assessed by the Number of Participant Drop-outs1 Participants
Secondary

Adherence With the Therapy as Assessed by the Number of Sessions Participants Attended

Time frame: Treatment Day 1- Day 10

ArmMeasureValue (MEAN)Dispersion
Active tDCSAdherence With the Therapy as Assessed by the Number of Sessions Participants Attended9.6 sessionsStandard Deviation 0.65
Sham tDCSAdherence With the Therapy as Assessed by the Number of Sessions Participants Attended9.0 sessionsStandard Deviation 1.73
Secondary

Feasibility of Home Intervention as Indicated by Participants' Perceptions of Level of Difficulty of Using Exercise Equipment as Assessed by the Visual Analog Scale (VAS)

Participants rated the level of difficulty of using exercise equipment on a scale of 0 to 10, with 0 indicating not difficult at all and 10 indicating very difficult.

Time frame: Day 10

ArmMeasureValue (MEAN)Dispersion
Active tDCSFeasibility of Home Intervention as Indicated by Participants' Perceptions of Level of Difficulty of Using Exercise Equipment as Assessed by the Visual Analog Scale (VAS)1.1 score on a scaleStandard Deviation 1.3
Sham tDCSFeasibility of Home Intervention as Indicated by Participants' Perceptions of Level of Difficulty of Using Exercise Equipment as Assessed by the Visual Analog Scale (VAS)1.7 score on a scaleStandard Deviation 1.5
Secondary

Feasibility of Home Intervention as Indicated by Participants' Perceptions of Level of Difficulty of Using tDCS as Assessed by the Visual Analog Scale (VAS)

Participants rated the level of difficulty of using tDCS on a scale of 0 to 10, with 0 indicating not difficult at all and 10 indicating very difficult

Time frame: Day 10

ArmMeasureValue (MEAN)Dispersion
Active tDCSFeasibility of Home Intervention as Indicated by Participants' Perceptions of Level of Difficulty of Using tDCS as Assessed by the Visual Analog Scale (VAS)1.1 score on a scaleStandard Deviation 1.3
Sham tDCSFeasibility of Home Intervention as Indicated by Participants' Perceptions of Level of Difficulty of Using tDCS as Assessed by the Visual Analog Scale (VAS)1 score on a scaleStandard Deviation 1.1
Secondary

Feasibility of Home Intervention as Indicated by Participants' Perceptions of Usefulness of the Intervention as Assessed by the Visual Analog Scale (VAS)

Participants rated the usefulness of the interventions on a scale of 0 to 10, with 0 indicating not useful at all and 10 indicating very useful.

Time frame: Day 10

ArmMeasureValue (MEAN)Dispersion
Active tDCSFeasibility of Home Intervention as Indicated by Participants' Perceptions of Usefulness of the Intervention as Assessed by the Visual Analog Scale (VAS)9.1 score on a scaleStandard Deviation 1.3
Sham tDCSFeasibility of Home Intervention as Indicated by Participants' Perceptions of Usefulness of the Intervention as Assessed by the Visual Analog Scale (VAS)9.1 score on a scaleStandard Deviation 0.9
Secondary

Grip Strength

Maximum force generated by hand muscles and measured with a hand-held dynamometer

Time frame: 6 weeks

ArmMeasureValue (MEAN)Dispersion
Active tDCSGrip Strength24.6 pounds (lbs)Standard Deviation 31.5
Sham tDCSGrip Strength11.3 pounds (lbs)Standard Deviation 10.7
Secondary

Grip Strength

Maximum force generated by hand muscles and measured with a hand-held dynamometer

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Active tDCSGrip Strength19.2 pounds (lbs)Standard Deviation 25.6
Sham tDCSGrip Strength9.3 pounds (lbs)Standard Deviation 7.5
Secondary

Grip Strength

Maximum force generated by hand muscles and measured with a hand-held dynamometer

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Active tDCSGrip Strength20.9 pounds (lbs)Standard Deviation 25.7
Sham tDCSGrip Strength10.8 pounds (lbs)Standard Deviation 10.1
Secondary

Number of Participants Who Had Adverse Events

Time frame: from baseline to 6 weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Active tDCSNumber of Participants Who Had Adverse Events1 Participants
Sham tDCSNumber of Participants Who Had Adverse Events2 Participants
Secondary

Self Care as Assessed by Score on the Self Care Subscale of the Spinal Cord Injury Independence Measure (SCIM III)

Total score on the Self Care Subscale of the Spinal Cord Injury Independence Measure (SCIM III) ranges between 0 to 20, with a higher score indicating a higher level of independence in daily functions.

Time frame: 6 weeks

ArmMeasureValue (MEAN)Dispersion
Active tDCSSelf Care as Assessed by Score on the Self Care Subscale of the Spinal Cord Injury Independence Measure (SCIM III)11.6 score on a scaleStandard Deviation 6.1
Sham tDCSSelf Care as Assessed by Score on the Self Care Subscale of the Spinal Cord Injury Independence Measure (SCIM III)7.5 score on a scaleStandard Deviation 5.8
Secondary

Self Care as Assessed by Score on the Self Care Subscale of the Spinal Cord Injury Independence Measure (SCIM III)

Total score on the Self Care Subscale of the Spinal Cord Injury Independence Measure (SCIM III) ranges between 0 to 20, with a higher score indicating a higher level of independence in daily functions.

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Active tDCSSelf Care as Assessed by Score on the Self Care Subscale of the Spinal Cord Injury Independence Measure (SCIM III)11.5 score on a scaleStandard Deviation 6.1
Sham tDCSSelf Care as Assessed by Score on the Self Care Subscale of the Spinal Cord Injury Independence Measure (SCIM III)7.3 score on a scaleStandard Deviation 6.4
Secondary

Self Care as Assessed by Score on the Self Care Subscale of the Spinal Cord Injury Independence Measure (SCIM III)

Total score on the Self Care Subscale of the Spinal Cord Injury Independence Measure (SCIM III) ranges between 0 to 20, with a higher score indicating a higher level of independence in daily functions.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Active tDCSSelf Care as Assessed by Score on the Self Care Subscale of the Spinal Cord Injury Independence Measure (SCIM III)11.1 score on a scaleStandard Deviation 6.4
Sham tDCSSelf Care as Assessed by Score on the Self Care Subscale of the Spinal Cord Injury Independence Measure (SCIM III)6.4 score on a scaleStandard Deviation 5.8

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026